June 11th, 2007, by Digital Davo | PDT, clinical trials
The Bispebjerg Hospital in Copenhagen is currently recruiting patients for a study comparing the “efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.” The study is titled Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea When aminolevulinic acid (Levulan) is applied to the skin and it is activated by exposure to blue light or IPL, …
March 7th, 2007, by Digital Davo | clinical trials
UPDATE: the trial is now closed to new applicants.
Fiona Fox, who is a PhD student at The Centre for Appearance Research, University of the West of England, Bristol, UK, is looking for young people with a skin condition to take part in some research online. She is looking for 11-18 year olds from any country. You can read some backgroud here at Teen Skin Issues.
If you have …
January 16th, 2007, by Digital Davo | clinical trials
Back in August 2006, via Rosacea News item Sydney: Study Participants Needed we appealed for people in Sydney to suffer from rosacea to be a part of a study. The study is looking for people who suffer from any of the following ; Frequent flushing or permanent redness on the cheeks, nose chin or forehead Small visible broken blood vessels on the face …
January 11th, 2007, by Digital Davo | clinical trials, finacea
Finacea is officially prescribed to be used twice per day. A new Clinical Trial is underway to compare the the application of Finacea twice a day and once per day. A Multicenter Trial to Assess the Efficacy and Safety of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily The trial is listed as using the drug azelaic acid, which …
November 4th, 2006, by Digital Davo | clinical trials
A recently published paper Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study, (Int J Dermatol. 2006 Jul;45(7):857-61) concluded that “Zinc sulfate was found to be a good option in the treatment of rosacea, as it was safe, effective and lacking important side-effects.” (Interestingly, this trial was from patients who attended the outpatient Clinic of Dermatology and Venereology at Baghdad Teaching Hospital between October 2002 and August …
|
|
|
|
|
|
|
|
|